Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010315 · ClinicalTrials.gov registry record
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
A clinical trial of Liver Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07010315: Recruiting study of Liver Cancer, sponsored by M.D. Anderson Cancer Center.
NCT07010315 is a study of Liver Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 40 participants, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07010315, a study of Liver Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop and test liver cancer prevention educational material.
Primary Outcome
Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational mat
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Testing
- BEHAVIORAL Usability Testing
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-04-30 |
What NCT07010315 shows while recruiting
NCT07010315 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Testing is the first listed.
NCT07010315 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07010315 about?
NCT07010315 is a clinical study titled "Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention". To develop and test liver cancer prevention educational material.
What is the current status of trial NCT07010315?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-05-01. Estimated completion is 2027-04-30.
What conditions does trial NCT07010315 study?
This clinical trial studies the following conditions: Liver Cancer.
What interventions are being tested in trial NCT07010315?
The interventions under investigation include: Cognitive Testing (BEHAVIORAL), Usability Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07010315?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07010315's enrollment target sits among peer trials
40 42nd of 78 higher than 36 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI